Planning for the Complexities of Product Launch

Pharmaceutical and biotech products progress through predictable lifecycle stages: early development, prelaunch, launch, growth, maturity, and finally, decline. The basic pattern is immutable, but along the way, crucial opportunities arise to increase uptake rates, attain higher ...

Opting for Project Zero Delay

When a pharma company embarks on a new drug development project, it’s obvious that the whole process from clinical trials to drug approval to launch phases could take several years.Perhaps, when a pharma company wants to be as promptly as possible, then it’s necessary that it ado ...

Risk Analysis and Strategic Thinking

Aspiring too many things at a time may boost one’s enthusiasm, but it lessens the tempo of steadiness. Importantly, it matters how one handles multitude of affairs in a short span of time. · Setting up fewer goals sounds good with less thinking to gauge risks and opportunities. W ...

Expanding Customer Base and Planning for New Product Launches

In today’s pharmaceutical landscape, it’s not sufficient to be simply a manufacturer of repute. If your product portfolio remains the same, without any new product launches, over the decades, then you cannot expect any remarkable growth in revenue.  · Either you’ve to expand your ...

Selecting for Project Zero Delay

When a pharma company embarks on a new drug development project, it’s obvious that the whole process from clinical trials to drug approval to launch phases could take several years. · Perhaps, when a pharma company wants to be as promptly as possible, then it’s necessary that it ...

New project.